Where does Noogen LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Noogen LLC ranks #49,159 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Noogen LLC hold?

Noogen LLC holds 5 US utility patents granted between 2020 and 2025, spanning 7 technology areas.

What is Noogen LLC's Innovation Score?

Noogen LLC has an Innovation Score of 30.3 out of 100 (34th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Noogen LLC focus on?

Noogen LLC's top technology area is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids) with 3 patents, ranking #282 of 896 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Noogen LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Noogen LLC.

What does claim depth mean for Noogen LLC's patents?

Noogen LLC's patents average 20.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Noogen LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Noogen LLC

USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Noogen ranks #49,159 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.

#49,159
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.3/100): 20.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49159 · Foreign Corporation #49,159 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,159/49,997
PHOTO-FINISH Nobotgames
CPC-NARROW C07H · 7 areas
INNOV-THIN 30.3/100
CLAIMS-DENSE 20.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Nobotgames, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Noogen’s 30.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (20%) Velocity 2.2 pts (7%) Breadth 9.4 pts (31%) Claim depth 12.5 pts (41%)

Qualcomm Incorporated · highest

85
Noogen · this assignee

30
3D Lighting… · lowest

7

What this shows Noogen's Innovation Score is 30.3/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Noogen?

Each dot is one of Noogen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Noogen’s own 20.8 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Noogen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Noogen's grants concentrate

Noogen LLC is a focused PatentsView assignee: 7 CPC subclasses with 60% of grants classified under C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2021. By volume, Noogen sits between Nobotgames, Inc. and Nordhydraulic AB.

Noogen's three-year grant acceleration

Noogen LLC shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nobotgames

5
Nodexus

5
Noha

5
Nok9 AB

5
Noporvis

5
Nora Systems

5
Norad Designs

5
Nordhydraulic AB

5
Noogen ◀

5

What this shows Noogen holds 5 patents at rank #49,058, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Noogen

By rank, the assignees closest to #49,058 in granted patent volume.

Leaders in C07H (Sugars)

Other assignees with the most granted patents in Noogen's primary technology class.

Noogen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Noogen LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	40.0%
2021	1	20.0%
2023	1	20.0%
2025partial year	1	20.0%

Which technologies does Noogen LLC patent most?

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C07D - Heterocyclic Compounds 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Noogen LLC's patent record in context - here's where to go next.

Noogen LLC's lead technology class is C07H (SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids), 60% of its portfolio - see every assignee active in that class. Explore C07H
Ranked #49,159 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Noogen LLC against Nobotgames, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.